In Conversation With an Oncologist: 340B and Its Impact on the Community
September 15th 2015The American Journal of Managed Care spoke with Bruce J. Gould, MD, medical director of Northwest Georgia Oncology Centers on the impact of the 340B drug pricing program on private oncology practices.
Read More
ASCO Publishes Policy Update on Genomic Testing for Cancer Susceptibility
September 1st 2015The Cancer Prevention and Ethics Committees of the American Society of Clinical Oncology have made several recommendations that address genetic and genomic testing policies for cancer risk assessment.
Read More